Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
The ins and outs of the tumor microbiome
From the Bullman Lab, Human Biology Division and Johnston Lab, Vaccine and Infectious Disease Division
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
Could bacterial enzymes drive cancer formation by directly modifying human DNA?
W.M. Keck Foundation grant will help scientists pioneer new technologies to find out
Immune booster may awaken body’s defenses against skin cancer
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
New guide helps clinicians navigate immunotherapy revolution in Merkel cell carcinoma
‘Real-world’ review accompanies new clinical care guidelines in rare skin cancer
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers